Zomedica Corp (NYSE American:ZOM) announced its delisting from the NYSE American exchange and transition to the OTCQB Venture Market, effective March 5, 2025. The company’s ticker symbol will change to ZOMDF.
The delisting is due to the NYSE American’s determination that Zomedica no longer meets listing requirements under Section 1003(f)(v) of the Company Guide, specifically citing the low selling price of common shares. Despite this change, Zomedica will maintain SEC reporting requirements and continue providing real-time trading data and financial disclosures through OTC Markets.
CEO Larry Heaton emphasized that while disappointed with the delisting, the company’s asset value and growth opportunities remain unchanged, with continued focus on developing veterinary products and maintaining investor engagement.
Zomedica Corp (NYSE American:ZOM) ha annunciato il suo…
